242
Participants
Start Date
May 9, 2019
Primary Completion Date
November 30, 2020
Study Completion Date
November 30, 2020
Artesunate-amodiaquine combination
Artesunate-amodiaquine (Coarsucam®: Sanofi-Aventis, France) is co-packaged as artesunate 50 mg and amodiaquine hydrochloride USP equivalent to amodiaquine base of 153.1 mg. Each child shall be given one, two or three tablets depending on the weight.
Artemether, Lumefantrine Drug Combination
Artemether-lumefantrine (Coartem®: Novartis, Switzerland) is formulated as tablets and will be provided in blister packs. Each tablet contains 20 mg artemether and 120 mg lumefantrine. Every pack has a picture showing how the drug should be given and contains two blisters for each day with one, two or three tablets depending on the weight of the child
District Medical Center Minkoa Meyos, Yaoundé
Malaria Research Capacity Development in West and Central Africa Consortium
UNKNOWN
Developing Excellence in Leadership, Training and Science Africa Initiative
UNKNOWN
Wellcome Trust
OTHER
United Kingdom Department for International Development
UNKNOWN
University of Yaounde 1
OTHER